• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MG53 蛋白保护主动脉瓣间质细胞免受膜损伤和纤维钙化重塑。

MG 53 Protein Protects Aortic Valve Interstitial Cells From Membrane Injury and Fibrocalcific Remodeling.

机构信息

1 Department of Surgery The Ohio State University Wexner Medical Center Columbus OH.

2 Department of Physiology and Cell Biology The Ohio State University Wexner Medical Center Columbus OH.

出版信息

J Am Heart Assoc. 2019 Feb 19;8(4):e009960. doi: 10.1161/JAHA.118.009960.

DOI:10.1161/JAHA.118.009960
PMID:30741589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405656/
Abstract

Background The aortic valve of the heart experiences constant mechanical stress under physiological conditions. Maladaptive valve injury responses contribute to the development of valvular heart disease. Here, we test the hypothesis that MG 53 (mitsugumin 53), an essential cell membrane repair protein, can protect valvular cells from injury and fibrocalcific remodeling processes associated with valvular heart disease. Methods and Results We found that MG 53 is expressed in pig and human patient aortic valves and observed aortic valve disease in aged Mg53-/- mice. Aortic valves of Mg53-/- mice showed compromised cell membrane integrity. In vitro studies demonstrated that recombinant human MG 53 protein protects primary valve interstitial cells from mechanical injury and that, in addition to mediating membrane repair, recombinant human MG 53 can enter valve interstitial cells and suppress transforming growth factor-β-dependent activation of fibrocalcific signaling. Conclusions Together, our data characterize valve interstitial cell membrane repair as a novel mechanism of protection against valvular remodeling and assess potential in vivo roles of MG 53 in preventing valvular heart disease.

摘要

背景

心脏的主动脉瓣在生理条件下会持续受到机械应力。适应性瓣膜损伤反应会导致瓣膜性心脏病的发生。在这里,我们验证了这样一个假设,即细胞膜修复蛋白 MG53(mitsugumin 53)可以保护瓣膜细胞免受与瓣膜性心脏病相关的损伤和纤维钙化重塑过程的影响。

方法和结果

我们发现 MG53 在心的猪和人主动脉瓣中表达,并观察到年老的 Mg53-/- 小鼠出现主动脉瓣疾病。Mg53-/- 小鼠的主动脉瓣表现出细胞外膜完整性受损。体外研究表明,重组人 MG53 蛋白可保护原代瓣膜间质细胞免受机械损伤,并且除了介导细胞膜修复之外,重组人 MG53 还可以进入瓣膜间质细胞并抑制转化生长因子-β 依赖性纤维钙化信号的激活。

结论

总的来说,我们的数据将瓣膜间质细胞膜修复作为一种防止瓣膜重塑的新保护机制,并评估了 MG53 在预防瓣膜性心脏病中的潜在体内作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/139adb8f6b5b/JAH3-8-e009960-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/d8c0cf0260c2/JAH3-8-e009960-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/553ee658e590/JAH3-8-e009960-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/d3c04e64000a/JAH3-8-e009960-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/554c68d7f914/JAH3-8-e009960-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/139adb8f6b5b/JAH3-8-e009960-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/d8c0cf0260c2/JAH3-8-e009960-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/553ee658e590/JAH3-8-e009960-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/d3c04e64000a/JAH3-8-e009960-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/554c68d7f914/JAH3-8-e009960-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c75/6405656/139adb8f6b5b/JAH3-8-e009960-g005.jpg

相似文献

1
MG 53 Protein Protects Aortic Valve Interstitial Cells From Membrane Injury and Fibrocalcific Remodeling.MG53 蛋白保护主动脉瓣间质细胞免受膜损伤和纤维钙化重塑。
J Am Heart Assoc. 2019 Feb 19;8(4):e009960. doi: 10.1161/JAHA.118.009960.
2
Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.二肽基肽酶-4 通过抑制瓣膜间质细胞中的胰岛素样生长因子-1 信号诱导主动脉瓣钙化。
Circulation. 2017 May 16;135(20):1935-1950. doi: 10.1161/CIRCULATIONAHA.116.024270. Epub 2017 Feb 8.
3
Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.转化生长因子-β1 促进纤维化,但可减轻作为三维钙化主动脉瓣疾病模型的瓣膜组织的钙化。
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H1123-H1141. doi: 10.1152/ajpheart.00651.2019. Epub 2020 Sep 28.
4
miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis.miRNA-141 是一种新型的骨形态发生蛋白 2 介导的主动脉瓣狭窄钙化调节因子。
J Thorac Cardiovasc Surg. 2012 Jul;144(1):256-62. doi: 10.1016/j.jtcvs.2011.10.097. Epub 2012 Feb 14.
5
Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.吡格列酮可减轻高胆固醇血症引起的瓣膜钙化。
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):523-32. doi: 10.1161/ATVBAHA.112.300794. Epub 2013 Jan 3.
6
Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease.在晚期主动脉瓣疾病中,存在对成骨信号的主动调节的证据。
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2482-6. doi: 10.1161/ATVBAHA.110.211029. Epub 2010 Sep 23.
7
A novel mouse model of aortic valve stenosis induced by direct wire injury.一种新型的通过直接钢丝损伤诱导的主动脉瓣狭窄小鼠模型。
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):270-8. doi: 10.1161/ATVBAHA.113.302610. Epub 2013 Dec 5.
8
Valvular interstitial cells suppress calcification of valvular endothelial cells.瓣膜间质细胞抑制瓣膜内皮细胞的钙化。
Atherosclerosis. 2015 Sep;242(1):251-260. doi: 10.1016/j.atherosclerosis.2015.07.008. Epub 2015 Jul 17.
9
Degenerative aortic valve disease and diabetes: Implications for a link between proteoglycans and diabetic disorders in the aortic valve.退行性主动脉瓣疾病与糖尿病:蛋白聚糖与主动脉瓣糖尿病紊乱之间联系的意义。
Diab Vasc Dis Res. 2019 May;16(3):254-269. doi: 10.1177/1479164118817922. Epub 2018 Dec 19.
10
Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.钙化性主动脉瓣疾病:第2部分——形态力学异常、基因重新表达以及性别对心室肥厚及其可逆性的影响
J Cardiovasc Transl Res. 2016 Aug;9(4):374-99. doi: 10.1007/s12265-016-9695-z. Epub 2016 May 16.

引用本文的文献

1
Association Between Lower Serum Mitsugumin 53 Levels and the Risk of Vascular Calcification in Hemodialysis Patients.血液透析患者血清中三宅五三蛋白水平降低与血管钙化风险之间的关联
Int J Nephrol Renovasc Dis. 2025 May 8;18:123-132. doi: 10.2147/IJNRD.S511844. eCollection 2025.
2
Mitsugumin 53 Inhibits Angiogenesis Through Regulating Focal Adhesion Turnover and Tip Cell Formation.三宅五三蛋白53通过调节粘着斑周转和顶端细胞形成来抑制血管生成。
J Cell Mol Med. 2025 Feb;29(4):e70439. doi: 10.1111/jcmm.70439.
3
Advances in the Study of MG53 in Cardiovascular Disease.

本文引用的文献

1
Potential role of MG53 in the regulation of transforming-growth-factor-β1-induced atrial fibrosis and vulnerability to atrial fibrillation.肌球蛋白重链结合蛋白 C 在转化生长因子-β1 诱导的心房纤维化及心房颤动易感性中的潜在作用。
Exp Cell Res. 2018 Jan 15;362(2):436-443. doi: 10.1016/j.yexcr.2017.12.007. Epub 2017 Dec 9.
2
MG53 is dispensable for T-tubule maturation but critical for maintaining T-tubule integrity following cardiac stress.MG53 在 T 管成熟过程中可有可无,但对于心脏应激后维持 T 管完整性至关重要。
J Mol Cell Cardiol. 2017 Nov;112:123-130. doi: 10.1016/j.yjmcc.2017.08.007. Epub 2017 Aug 16.
3
Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
MG53在心血管疾病中的研究进展
Int J Gen Med. 2023 Dec 23;16:6073-6082. doi: 10.2147/IJGM.S435030. eCollection 2023.
4
MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury.MG53通过泛素化依赖性RIPK1降解抑制坏死性凋亡,对缺血/再灌注损伤后的心脏起到保护作用。
Front Cardiovasc Med. 2022 May 31;9:868632. doi: 10.3389/fcvm.2022.868632. eCollection 2022.
5
MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression.MG53可维持神经肌肉接头完整性并减缓肌萎缩侧索硬化症的疾病进展。
Antioxidants (Basel). 2021 Sep 25;10(10):1522. doi: 10.3390/antiox10101522.
6
MG53 suppresses NF-κB activation to mitigate age-related heart failure.MG53 通过抑制 NF-κB 激活来减轻与年龄相关的心力衰竭。
JCI Insight. 2021 Sep 8;6(17):e148375. doi: 10.1172/jci.insight.148375.
7
Cardiac effects and clinical applications of MG53.MG53的心脏效应及临床应用
Cell Biosci. 2021 Jun 28;11(1):115. doi: 10.1186/s13578-021-00629-x.
8
Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration.肌肉多器官串扰,MG53 作为一种肌因子促进组织修复和再生。
Curr Opin Pharmacol. 2021 Aug;59:26-32. doi: 10.1016/j.coph.2021.04.005. Epub 2021 May 27.
9
Plasma membrane integrity: implications for health and disease.细胞膜完整性:对健康和疾病的影响。
BMC Biol. 2021 Apr 13;19(1):71. doi: 10.1186/s12915-021-00972-y.
10
Plasma membrane integrity in health and disease: significance and therapeutic potential.健康与疾病中的质膜完整性:意义与治疗潜力。
Cell Discov. 2021 Jan 19;7(1):4. doi: 10.1038/s41421-020-00233-2.
主动脉瓣狭窄的病理生理学:它既是纤维钙化性的又是性别特异性的吗?
Physiology (Bethesda). 2017 May;32(3):182-196. doi: 10.1152/physiol.00025.2016.
4
Aortic valve disease in the older adult.老年患者的主动脉瓣疾病
J Geriatr Cardiol. 2016 Dec;13(12):941-944. doi: 10.11909/j.issn.1671-5411.2016.12.004.
5
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice.用于小鼠瓣膜性心脏病综合表型特征分析的超声心动图方法与方案
J Vis Exp. 2017 Feb 14(120):54110. doi: 10.3791/54110.
6
Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation.心脏瓣膜的生长和成熟会导致内皮细胞分布改变、功能受损、代谢降低以及细胞增殖减少。
J Mol Cell Cardiol. 2016 Nov;100:72-82. doi: 10.1016/j.yjmcc.2016.10.006. Epub 2016 Oct 15.
7
Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery.解码心脏成熟过程中的长链非编码RNA:功能发现路线图
Circ Cardiovasc Genet. 2016 Oct;9(5):395-407. doi: 10.1161/CIRCGENETICS.115.001363. Epub 2016 Sep 2.
8
TGF-β: the master regulator of fibrosis.TGF-β:纤维化的主调控因子。
Nat Rev Nephrol. 2016 Jun;12(6):325-38. doi: 10.1038/nrneph.2016.48. Epub 2016 Apr 25.
9
MG53 permeates through blood-brain barrier to protect ischemic brain injury.MG53可穿透血脑屏障以保护缺血性脑损伤。
Oncotarget. 2016 Apr 19;7(16):22474-85. doi: 10.18632/oncotarget.7965.
10
Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.人类心脏中缺乏MG53,这使其无法作为心肌损伤的生物标志物或内源性心脏保护因子。
Cardiovasc Res. 2016 May 15;110(2):178-87. doi: 10.1093/cvr/cvw017. Epub 2016 Jan 19.